ACRO Biomedical Co., Ltd. (TPEX:6748)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
79.50
+2.20 (2.85%)
Aug 15, 2025, 1:59 PM CST
216.73%
Market Cap 4.81B
Revenue (ttm) 44.23M
Net Income (ttm) -62.09M
Shares Out 61.22M
EPS (ttm) -1.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 304,993
Average Volume 1,929,162
Open 77.30
Previous Close 77.30
Day's Range 76.80 - 83.30
52-Week Range 22.35 - 94.30
Beta 0.73
RSI 59.51
Earnings Date Aug 11, 2025

About ACRO Biomedical

ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials. The company offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines. ACRO Biomedical Co., Ltd. was founded in 2014 and is based in Kaohsiung, Taiwan. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2014
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6748
Full Company Profile

Financial Performance

In 2024, ACRO Biomedical's revenue was 44.23 million, a decrease of -13.38% compared to the previous year's 51.06 million. Losses were -62.09 million, 49.9% more than in 2023.

Financial Statements

News

There is no news available yet.